Levent YAŞAR, İbrahim KARACA, Murat EKİN, İsmail ALAY, Hüseyin CENGİZ, Cihan KAYA

SEZARYEN ESNASINDA RASTLANTISAL OLARAK SAPTANAN GASTROİNTESTİNAL STROMAL TÜMÖR: OLGU SUNUMU VE LİTERATÜR TARAMASI

Gastrointestinal stromal tümörler (GIST'ler) gastrointestinal sistemin interstisyel Cajal hücrelerinden gelişen en yaygın mezenkimal tümörlerdir. GIST’lerin görüldüğü yaş dağılımı göz önüne alındığında, gebelik veya puerperium sırasında GIST tanısı çok nadirdir. 26 yaşında primigravid bir kadın acil servisimize doğum sancısı ile başvurdu. Sezaryen operasyonu sırasında, ince bağırsağın antimezenterik duvarından kaynaklanan 7 cm'lik bir kitle saptandı. Hastaya genel cerrahi ekibi tarafından sezaryen sonrası 38. günde ince barsak rezeksiyonu ve parsiyel omentektomi operasyonu uygulandı. Patolojik incelemede 9x6x6 cm infiltratif gastrointestinal stromal tümör saptandı. Medikal onkolojinin önerisiyle Imatinib tedavisi başladı. Hasta halen tıbbi onkoloji kliniği tarafından takip edilmektedir. Sonuç olarak, sezaryen sırasında batın içinin eksplorasyonu asemptomatik kitlelerin tespiti açısından önemlidir.

Incidental Diagnosis of a Gastrointestinal Stromal Tumor during Cesarean Section: A case Report and Review of the Literature

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors that developfrom the interstitial Cajal cells of the gastrointestinal tract. Given the age distribution of ocurrence,a diagnosis of GISTs during pregnancy or puerperium is very uncommon. A 26-year-old primigravidwoman was admitted to our emergency department with labor pain. During cesarean a 7 cm masswas found incidentally, which originated from the antimesenteric wall of the small intestine. Thepatient underwent a small bowel resection and partial omentectomy on the 38th day after cesareansection by the general surgical team. Pathology revealed a 9x6x6 cm infiltrative gastrointestinalstromal tumor. Imatinib therapy was started with medical oncology’s recommendation. Thepatient is still being followed by the medical oncology clinic. In conclusion, exploration of theabdomen during a cesarean section is important for the detection of asymptomatic masses.

PDF

___

Miettinen M, Lasota J. Gastrointestinal stromal tumors—definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Archiv, vol. 438, no. 1, pp. 1–12, 2001.
Tran T, Davila JA, El-Serag HB. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol 2005; 100:162.
Nilsson B, Bumming P, Meis-Kindblom JM, Oden A, Dortok A, Gustavsson B, et al. Gastrointestinal stromal tumors: the incidence, prevalence clinical course, and prognostication in the pre-imatinib mesylate era-a population based study in western Sweden. Cancer. 2005; 103:821–9.
DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000; 231:51.
Stubbs BM, Desai A, Singh S, Seddon B, Khan F. Gastrointestinal stromal tumour in pregnancy. BMJ Case Rep. 2011 Jul 20;2011.
Varras M, Vlachakos N, Akrivis C, Vasilakaki T, Skafida E. Malignant gastrointestinal stromal tumor presenting with hemoperitoneum in puerperium: report of a case with review of the literature. World J Surg Oncol. 2010; 8:95.
Cuerva-González MJ, Lacoponi S, de la Calle-Fernández M, Pozo-Krielinger J. Gastrointestinal stromal tumor in pregnancy and control. Case report. Ginecol Obstet Mex. 2010 Dec;78(12):697-702.
Scherjon S, Lam WF, Gelderblom H, Jansen FW. Gastrointestinal stromal tumor in pregnancy: a case report. Case Rep Med. 2009; 2009:456402.
Coveney S. Twin pregnancy complicated by an adnexal mass. AJUM. 2011;14(1):31–3.
Igras ET, Fosh BG, Neuhaus SJ. Maternal GIST in twin pregnancy: case report of a rare and complex management challenge. Gynecol Oncol Case Rep. 2012;2(4):133–5.
Haloob N, Slesser AA, Haloob AR, Khan F, Bostanci G, Abdulla A. An elective combined caesarean section and small bowel GIST resection during the third trimester of pregnancy: report of a case. Int J Surg Case Rep. 2013;4(1):121–4.
Valente PT, Fine BA, Parra C, Schroeder B. Gastric stromal tumor with peritoneal nodules in pregnancy: tumor spread or rare variant of diffuse leiomyomatosis. Gynecol Oncol. 1996;63(3):392–7.
Lanzafame S, Minutolo V, Caltabiano R, Minutolo O, Marino B, Gagliano G, et al. About a case of GIST occurring during pregnancy with immunohistochemical expression of epidermal growth factor receptor and progesterone receptor. Pathol Res Pract. 2006;202(2):119–23.
Parampalli U, Crossland C, Longley J, Morrison I, Sayegh M. A Rare Case of Gastrointestinal Stromal Tumour in Pregnancy Presenting with Upper Gastrointestinal Bleeding. J Gastrointest Canc (2012) 43 (Suppl 1): S80–S83.
Jove Oblitas WDC, Abril Barreda MJ. Gastrointestinal stromal tumor in young pregnant woman: case report. Rev Gastroenterol Peru. 2017 Apr-Jun;37(2):182-186.
Charif I, Khalil N, Ousadden A, El Benjelloun B, Slimani O, Alaoui F, et al. Pregnancy with gastric stromal tumor. Case Rep Clin Med. 2014; 3:571–6.
Gozukara I, Dilek Kutlu TU, Durukan H, Dusmez AD, Kabil KS, Dilek S. Extragastrointestinal stromal tumor during pregnacy. Case Rep Obstet Gynecol. 2012; 2012:846747.
Mahdaui S, Hissane EM, Oubaid B, Hermas S, Noun M, Samouh N et al. Pregnancy and extra-gastrointestinal stromal tumor: an exceptional association. J Gynecol Obstet Biol Reprod (Paris). 2012;41(5):485–8.
Goel N, Malik R, Rathi B, Bhaskaran S, Rajaram S, Mehta S, et al. Pregnancy with metastatic gastrointestinal stromal tumor (GIST) on imatinib chemotherapy: an oncologist’s nightmare and obstetrician’s dilemma. J Gastrointest Cancer. 2013;44(1):115–7.
Towu E, Stanton M. Gastrointestinal stromal tumor presenting with severe bleeding: a review of the molecular biology. Pediatr Surg Int 2006, 22:462-464.
Zighelboim I, Gwendolyn H, Kunda A, Gutierrez C, Edwards C: Gastrointestinal stromal tumor presenting as a pelvic mass. GynecolOncol 2003, 91:630-635.
Singer S, Rubin BP, Lux ML, Chen CJ, Demetri GD, Fletcher CD, et al. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol 2002; 20:3898.
Emory TS, Sobin LH, Lukes L, Lee DH, O'Leary TJ. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. American Journal of Surgical Pathology, vol. 23, no. 1, pp. 82–87, 1999.
Blay JY, Von Mehren M, Blackstein ME. Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors. Cancer. 2010; 116:5126–372.
Eisenberg BL, Harris J, Blanke CD, Demetri GD, Heinrich MC, Watson JC, et al. Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable Gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ ACRIN 6665. J Surg Oncol. 2009; 99:42–7.
Bauer S, Rutkowski P, Hohenberger P, Miceli R, Fumagalli E, Siedlecki JA, et al. Long term follow-up of patients with GIST undergoing metastasectomyin the era of imatinib- analysis of prognostic factors (EORTC-STBSG collaborative study). Eur J Surg Oncol. 2014; 40:412–9.
US Department of Health and Human Services; Centers for Disease Control and Prevention; National Institute for Occupational Safety and Health. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings 2016.